AKZO NOBEL SPONS.ADRS 1/3 (AKUP) — Financial Flexibility Index
AKZO NOBEL SPONS.ADRS 1/3 (AKUP) has a Financial Flexibility Index of 0.02x as of June 2026. Free cash flow of €232.00 Million (operating CF €170.00 Million minus capex €62.00 Million) represents 0% of total liabilities (€11.10 Billion). Check AKZO NOBEL SPONS.ADRS 1/3 investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
AKZO NOBEL SPONS.ADRS 1/3 Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for AKZO NOBEL SPONS.ADRS 1/3 across 4 annual periods. For the full cash flow conversion analysis, see cash flow conversion of AKZO NOBEL SPONS.ADRS 1/3.
Annual Financial Flexibility Index for AKZO NOBEL SPONS.ADRS 1/3 (2022–2025)
Year-by-year free cash flow to debt coverage for AKZO NOBEL SPONS.ADRS 1/3. Explore AKZO NOBEL SPONS.ADRS 1/3 (AKUP) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.13x | €1.22 Billion | €915.00 Million | €9.13 Billion | ▲ +29.2% |
| 2024 | 0.10x | €979.00 Million | €673.00 Million | €9.43 Billion | ▼ -26.4% |
| 2023 | 0.14x | €1.41 Billion | €1.13 Billion | €10.01 Billion | ▲ +159.0% |
| 2022 | 0.05x | €555.00 Million | €263.00 Million | €10.19 Billion | — |